An essential role for mast cells as modulators of neutrophils influx in collagen-induced arthritis in the mouse

Laboratory Investigation

Volumn 91, Issue 1, 2011, Pages 33-42

  Pimentel, Tatiana Aparecida ^a   Sampaio, André Luiz Franco ^b,c   D'Acquisto, Fulvio ^b   Perretti, Mauro ^b   Oliani, Sonia Maria ^a,d  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

collagen induced arthritis; digits; knees; mast cells; nedocromil; neutrophils; prednisolone

Indexed keywords

NEDOCROMIL; PREDNISOLONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DBA 1 MOUSE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; KNEE; MALE; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL INFLUX; NONHUMAN; PRIORITY JOURNAL; SYNOVIUM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; FORELIMB; GLUCOCORTICOIDS; HINDLIMB; KNEE JOINT; LEUKOCYTE COUNT; MAST CELLS; MICE; MICE, INBRED DBA; NEDOCROMIL; NEUTROPHIL INFILTRATION; NEUTROPHILS; PREDNISOLONE; SYNOVIAL MEMBRANE; TIME FACTORS;

EID: 78650787484     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2010.140     Document Type: Article

References (58)

1. Williams A, Richards P, Thomas E, et al. Interferon-gamma protects against the development of structural damage in experimental arthritis by regulating polymorphonuclear neutrophil influx into diseased joints. Arthritis Rheum 2007;56:2244-2254.
2. Grespan R, Fukada S, Lemos H, et al. CXCR2-specific chemokines mediate leukotriene B4-dependent recruitment of neutrophils to inflamed joints in mice with antigen-induced arthritis. Arthritis Rheum 2008;58:2030-2040.
3. Tetlow L, Woolley D. Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies. Ann Rheum Dis 1995;54:896-903.
4. Firestein G. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-361.
5. Eklund K. Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapy. Immunol Rev 2007;217: 38-52.
6. Metcalfe D. Mast cells and mastocytosis. Blood 2008;112:946-956.
7. Kalesnikoff J, Galli S. New developments in mast cell biology. Nat Immunol 2008;9:1215-1223.
8. Galli S, Kalesnikoff J, Grimbaldeston M, et al. Mast cells as 'tunable' effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005;23:749-786.
9. Rivera J, Gilfillan A. Molecular regulation of mast cell activation. J Allergy Clin Immunol 2006;117:1214-1225, quiz 1226.
10. Galli S, Grimbaldeston M, Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 2008;8:478-486.
11. Sylvestre D, Ravetch J. A dominant role for mast cell Fc receptors in the Arthus reaction. Immunity 1996;5:387-390.
12. Magnusson S, Pejler G, Kleinau S, et al. Mast cell chymase contributes to the antibody response and the severity of autoimmune arthritis. FASEB J 2009;23:875-882.
13. Malone D, Irani A, Schwartz L, et al. Mast cell numbers and histamine levels in synovial fluids from patients with diverse arthritides. Arthritis Rheum 1986;29:956-963.
14. Woolley D. The mast cell in inflammatory arthritis. N Engl J Med 2003;348:1709-1711.
15. Shin K, Nigrovic P, Crish J, et al. Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. J Immunol 2009;182:647-656.
16. Riley P, Mather M, Keogh R, et al. Activity of nedocromil sodium in mast-cell-dependent reactions in the rat. Int Arch Allergy Appl Immunol 1987;82:108-110.
17. Ahluwalia P, Anderson D, Wilson S, et al. Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms. J Allergy Clin Immunol 2001;108:449-454.
18. Arnett H, Viney J. Considerations for the sensible use of rodent models of inflammatory disease in predicting efficacy of new biological therapeutics in the clinic. Adv Drug Deliv Rev 2007;59:1084-1092.
19. Amirahmadi S, Pho M, Gray R, et al. An arthritogenic monoclonal antibody to type II collagen, CII-C1, impairs cartilage formation by cultured chondrocytes. Immunol Cell Biol 2004;82:427-434.
20. Yang Y, Hutchinson P, Leech M, et al. Exacerbation of adjuvant arthritis by adrenalectomy is associated with reduced leukocyte lipocortin 1. J Rheumatol 1997;24:1758-1764.
21. Tanaka D, Kagari T, Doi H, et al. Essential role of neutrophils in antitype II collagen antibody and lipopolysaccharide-induced arthritis. Immunology 2006;119:195-202.
22. Kouskoff V, Korganow A, Duchatelle V, et al. Organ-specific disease provoked by systemic autoimmunity. Cell 1996;87:811-822.
23. Wipke B, Allen P. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol 2001;167:1601-1608.
24. Raud J. Intravital microscopic studies on acute mast cell-dependent inflammation. Acta Physiol Scand Suppl 1989;578:1-58.
25. Schramm R, Thorlacius H. Neutrophil recruitment in mast cell-dependent inflammation: inhibitory mechanisms of glucocorticoids. Inflamm Res 2004;53:644-652.
26. Pejler G, Abrink M, Ringvall M, et al. Mast cell proteases. Adv Immunol 2007;95:167-255.
27. Caughey G. Mast cell tryptases and chymases in inflammation and host defense. Immunol Rev 2007;217:141-154.
28. Tani K, Ogushi F, Kido H, et al. Chymase is a potent chemoattractant for human monocytes and neutrophils. J Leukoc Biol 2000;67:585-589.
29. Huang C, De Sanctis G, O'Brien P, et al. Evaluation of the substrate specificity of human mast cell tryptase beta I and demonstration of its importance in bacterial infections of the lung. J Biol Chem 2001;276:26276- 26284.
30. Gaboury J, Johnston B, Niu X, et al. Mechanisms underlying acute mast cell-induced leukocyte rolling and adhesion in vivo. J Immunol 1995;154:804-813.
31. Kubes P, Granger D. Leukocyte-endothelial cell interactions evoked by mast cells. Cardiovasc Res 1996;32:699-708.
32. Tailor A, Tomlinson A, Salas A, et al. Dexamethasone inhibition of leucocyte adhesion to rat mesenteric postcapillary venules: role of intercellular adhesion molecule 1 and KC. Gut 1999;45:705-712.
33. Perretti M, Harris J, Flower R. A role for endogenous histamine in interleukin-8-induced neutrophil infiltration into mouse air-pouch: investigation of the modulatory action of systemic and local dexamethasone. Br J Pharmacol 1994;112:801-808.
34. Ajuebor M, Das A, Virág L, et al. Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. J Immunol 1999;162:1685-1691.
35. Triggiani M, Petraroli A, Loffredo S, et al. Differentiation of monocytes into macrophages induces the upregulation of histamine H1 receptor. J Allergy Clin Immunol 2007;119:472-481.
36. Jutel M, Akdis M, Akdis C. Histamine, histamine receptors and their role in immune pathology. Clin Exp Allergy 2009;39:1786-1800.
37. Takeshita K, Sakai K, Bacon K, et al. Critical role of histamine H4 receptor in leukotriene B4 production and mast cell-dependent neutrophil recruitment induced by zymosan in vivo. J Pharmacol Exp Ther 2003;307:1072-1078.
38. Lee D, Friend D, Gurish M, et al. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002; 297:1689-1692.
39. Metz M, Grimbaldeston M, Nakae S, et al. Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 2007;217: 304-328.
40. Paniagua R, Sharpe O, Ho P, et al. Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis. J Clin Invest 2006;116:2633-2642.
41. Magnusson S, Andrén M, Nilsson K, et al. Amelioration of collagen-induced arthritis by human recombinant soluble FcgammaRIIb. Clin Immunol 2008;127:225-233.
42. Eyles J, Hickey M, Norman M, et al. A key role for G-CSF-induced neutrophil production and trafficking during inflammatory arthritis. Blood 2008;112:5193-5201.
43. Rhen T, Cidlowski J. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 2005;353:1711-1723.
44. RM A, ST H. Nedocromil sodium: a review of its anti-inflammatory properties and clinical activity in the treatment of asthma. In: Kay A (edn). Allergy and Asthma. New Trends and Approaches to Therapy. Oxford: Blackwell Scientific Publications, 1989, pp 171-188.
45. van Everdingen A, Jacobs J, Siewertsz Van Reesema D, et al. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 2002;136:1-12.
46. Ciulla T, Walker J, Fong D, et al. Corticosteroids in posterior segment disease: an update on new delivery systems and new indications. Curr Opin Ophthalmol 2004;15:211-220.
47. Krivic A, Majerovic M, Jelic I, et al. Modulation of early functional recovery of Achilles tendon to bone unit after transection by BPC 157 and methylprednisolone. Inflamm Res 2008;57:205-210.
48. Berenstein E, Garcia-Gil M, Siraganian R. Dexamethasone inhibits receptor-activated phosphoinositide breakdown in rat basophilic leukemia (RBL-2H3) cells. J Immunol 1987;138:1914-1918.
49. Andrade M, Hiragun T, Beaven M. Dexamethasone suppresses antigen-induced activation of phosphatidylinositol 3-kinase and downstream responses in mast cells. J Immunol 2004;172:7254-7262.
50. Nakamura R, Okunuki H, Ishida S, et al. Gene expression profiling of dexamethasone-treated RBL-2H3 cells: induction of anti-inflammatory molecules. Immunol Lett 2005;98:272-279.
51. Park S, Beaven M. Mechanism of upregulation of the inhibitory regulator, src-like adaptor protein (SLAP), by glucocorticoids in mast cells. Mol Immunol 2009;46:492-497.
52. Mihara K, Almansa C, Smeets R, et al. A potent and selective p38 inhibitor protects against bone damage in murine collagen-induced arthritis: a comparison with neutralization of mouse TNFalpha. Br J Pharmacol 2008;154:153-164.
53. Xu X, Weksler-Zangen S, Pikarsky A, et al. Mast cells involvement in the inflammation and fibrosis development of the TNBS-induced rat model of colitis. Scand J Gastroenterol 2002;37:330-337.
54. Zampeli E, Tiligada E. The role of histamine H4 receptor in immune and inflammatory disorders. Br J Pharmacol 2009;157:24-33.
55. Kobayashi Y, Okunishi H. Mast cells as a target of rheumatoid arthritis treatment. Jpn J Pharmacol 2002;90:7-11.
56. Cheng J, Arnold R. Pharmacoeconomic review of medical management of persistent asthma. Allergy Asthma Proc; 29: 109-122.
57. Jin Y, Silverman A, Vannucci S. Mast cells are early responders after hypoxia-ischemia in immature rat brain. Stroke 2009;40:3107-3112.
58. Iwai H, Kozono Y, Hirose S, et al. Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation. J Immunol 2002;169:4332-4339.